These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Orientative clinical trials on the effects of dihydroxyphenylalanine (1-dopa) in endogenous depression]. Ingvarsson CG Arzneimittelforschung; 1965 Aug; 15(8):849-52. PubMed ID: 5898634 [No Abstract] [Full Text] [Related]
23. L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients. Goodwin FK; Murphy DL; Brodie HK; Bunney WE Biol Psychiatry; 1970 Oct; 2(4):341-66. PubMed ID: 4920729 [No Abstract] [Full Text] [Related]
24. L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism. Yahr MD; Duvoisin RC; Hoehn MM; Schear MJ; Barrett RE Trans Am Neurol Assoc; 1968; 93():56-63. PubMed ID: 4885744 [No Abstract] [Full Text] [Related]
25. The patient's view of L-Dopa after one year's therapy. Hildick-Smith M Gerontol Clin (Basel); 1973; 15(2):74-83. PubMed ID: 4753782 [No Abstract] [Full Text] [Related]
26. [Longtime study on the effects of L-dopa therapy in parkinsonism]. Fischer PA; Schneider E; Jacobi P; Maxion H Nervenarzt; 1973 Mar; 44(3):128-35. PubMed ID: 4572536 [No Abstract] [Full Text] [Related]
27. The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report. Wycis HT Confin Neurol; 1972; 34(2):130-5. PubMed ID: 4666056 [No Abstract] [Full Text] [Related]
29. Experience with furanidyl-fluorouracil in advanced tumours of the breast. Cichy A; Jurga L; Klvana M Neoplasma; 1974; 21(6):723-32. PubMed ID: 4614094 [No Abstract] [Full Text] [Related]
30. Failures of L-dopa. Paulson GW Ohio State Med J; 1973 Dec; 69(12):896-8. PubMed ID: 4769406 [No Abstract] [Full Text] [Related]
31. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease. Andrews CJ; Somerville B Med J Aust; 1974 Mar; 1(12):429-32. PubMed ID: 4598384 [No Abstract] [Full Text] [Related]
32. [Trial of L-dopa as hypotensive medication in arterial hypertension. Preliminary report]. Torres Zamora M; García Monterd G; Chávez Domínguez R; Chávez Lara B; Serrano PA Arch Inst Cardiol Mex; 1974; 44(2):267-74. PubMed ID: 4599277 [No Abstract] [Full Text] [Related]
33. [Treatment of depression with chlorimipramine. Review of literature and personal clinical experiences]. Rossner M; Ficker F Psychiatr Neurol Med Psychol (Leipz); 1972 Jul; 24(7):369-83. PubMed ID: 4562548 [No Abstract] [Full Text] [Related]
34. Letter: Levodopa as a treatment of obesity. Quaade F; Pakkenberg H; Juhl E Acta Med Scand; 1974; 195(1-2):129. PubMed ID: 4593668 [No Abstract] [Full Text] [Related]
35. A preliminary report of Australian trials with L-dopa. Selby G Aust N Z J Med; 1971 May; 1():Suppl 1:48-56. PubMed ID: 4949275 [No Abstract] [Full Text] [Related]
36. [Effect of L-dopa on hepatic coma]. Jorge AD; Sanchez D Schweiz Rundsch Med Prax; 1973 Jul; 62(27):868-72. PubMed ID: 4578027 [No Abstract] [Full Text] [Related]
37. L-dopa in the treatment of Parkinsonism. Brezný I; Buranová D; Cernácek J; Trávniková M Act Nerv Super (Praha); 1972; 14(2):96. PubMed ID: 5040182 [No Abstract] [Full Text] [Related]
38. [Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor]. Stammler A; Vielhaber K Fortschr Neurol Psychiatr Grenzgeb; 1972 Oct; 40(10):564-8. PubMed ID: 4565521 [No Abstract] [Full Text] [Related]
39. [Combination of L-dopa and sulpiride in the treatment of Parkinson's disease]. Brion S; Guérin R Cah Med; 1973 Jul; 14(8):695-8. PubMed ID: 4602472 [No Abstract] [Full Text] [Related]